Literature DB >> 18230405

Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia.

Suba Krishnan1, Jamie Siegel, Gene Pullen, Megan Hevelow, Carlton Dampier, Marie Stuart.   

Abstract

We evaluated vWF profiles in children and adolescents with SCD and sleep hypoxemia. Mean vWF:Ag levels were significantly elevated in the SCD-hypoxemia group when compared with SCD-normoxia and control groups (p=0.007); and correlated inversely with pulse oximetry (r=-0.54, p=0.01). Densitographic analyses of vWF multimer distribution also showed an inverse correlation between %HMW-multimers and oxygen saturation (r=-0.62, p=0.03). The previously reported association between nocturnal desaturation and SCD vascular complications, including stroke, may be influenced by hypoxemic modulation of vWF as noted in this study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230405      PMCID: PMC2555967          DOI: 10.1016/j.thromres.2007.12.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  21 in total

Review 1.  Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.

Authors:  Ulrich Budde; Hubert J Metzner; Heinz-Georg Müller
Journal:  Semin Thromb Hemost       Date:  2006-09       Impact factor: 4.180

2.  ADAMTS13 activity in sickle cell disease.

Authors:  John-John B Schnog; Johanna A Kremer Hovinga; Soraya Krieg; Sakir Akin; Bernhard Lämmle; Dees P M Brandjes; Melvin R Mac Gillavry; Fred D Muskiet; Ashley J Duits
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

Review 3.  Sickle cell vaso-occlusion.

Authors:  Elaine Y Chiang; Paul S Frenette
Journal:  Hematol Oncol Clin North Am       Date:  2005-10       Impact factor: 3.722

4.  Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor.

Authors:  D K Kaul; H M Tsai; X D Liu; M T Nakada; R L Nagel; B S Coller
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

5.  Measurement of hemoglobin saturation by oxygen in children and adolescents with sickle cell disease.

Authors:  J P Needleman; B N Setty; L Varlotta; C Dampier; J L Allen
Journal:  Pediatr Pulmonol       Date:  1999-12

6.  Standards and indications for cardiopulmonary sleep studies in children. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

7.  Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation.

Authors:  D J Pinsky; Y Naka; H Liao; M C Oz; D D Wagner; T N Mayadas; R C Johnson; R O Hynes; M Heath; C A Lawson; D M Stern
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

8.  Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls.

Authors:  D Hagger; S Wolff; J Owen; D Samson
Journal:  Blood Coagul Fibrinolysis       Date:  1995-04       Impact factor: 1.276

9.  Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.

Authors:  Mehmet Polatli; Aysel Cakir; Orhan Cildag; A Zahit Bolaman; Cigdem Yenisey; Yavuz Yenicerioglu
Journal:  J Thromb Thrombolysis       Date:  2007-07-10       Impact factor: 2.300

Review 10.  The presence of active von Willebrand factor under various pathological conditions.

Authors:  Evelyn Groot; Philip G de Groot; Rob Fijnheer; Peter J Lenting
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

View more
  13 in total

1.  Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease.

Authors:  Enrico M Novelli; Gregory J Kato; Mariana E Hildesheim; Suchitra Barge; Michael P Meyer; Jay Lozier; Andrea Cortese Hassett; Margaret V Ragni; Jeffrey S Isenberg; Mark T Gladwin
Journal:  Haematologica       Date:  2013-11       Impact factor: 9.941

2.  Role of the coagulation system in the pathogenesis of sickle cell disease.

Authors:  Md Nasimuzzaman; Punam Malik
Journal:  Blood Adv       Date:  2019-10-22

Review 3.  von Willebrand factor: an emerging target in stroke therapy.

Authors:  Simon F De Meyer; Guido Stoll; Denisa D Wagner; Christoph Kleinschnitz
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

4.  Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease.

Authors:  Charles T Quinn; Marie J Stuart; Karen Kesler; Kenneth I Ataga; Winfred C Wang; Lori Styles; Kim Smith-Whitley; Ted Wun; Ashok Raj; Lewis L Hsu; Suba Krishnan; Frans A Kuypers; Yamaja Setty; Seungshin Rhee; Nigel S Key; George R Buchanan
Journal:  Br J Haematol       Date:  2011-08-16       Impact factor: 6.998

5.  The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma.

Authors:  Junmei Chen; William E Hobbs; Jennie Le; Peter J Lenting; Philip G de Groot; José A López
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

Review 6.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 7.  Interplay between coagulation and vascular inflammation in sickle cell disease.

Authors:  Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

Review 8.  How I diagnose and treat venous thromboembolism in sickle cell disease.

Authors:  Arun S Shet; Ted Wun
Journal:  Blood       Date:  2018-05-15       Impact factor: 22.113

Review 9.  Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Authors:  Denis Noubouossie; Nigel S Key; Kenneth I Ataga
Journal:  Blood Rev       Date:  2015-12-24       Impact factor: 8.250

10.  Intravascular hemolysis triggers ADP-mediated generation of platelet-rich thrombi in precapillary pulmonary arterioles.

Authors:  Tomasz Brzoska; Ravi Vats; Margaret F Bennewitz; Egemen Tutuncuoglu; Simon C Watkins; Margaret V Ragni; Matthew D Neal; Mark T Gladwin; Prithu Sundd
Journal:  JCI Insight       Date:  2020-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.